Ritlecitinib also effective in patients with total hair loss Presented ByDr Melissa Piliang, Cleveland Clinic, USA TrialPhase 3, ALLEGRO ConferenceAAD 2024 22 April, 2024 14:57
Alopecia areata: encouraging response rates with JAK3/TEC inhibition Presented ByProf. Brett King, Yale University School of Medicine, USA TrialALLEGRO ConferenceEADV 2021 18 November, 2021 13:11